Navigation Links
Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
Date:10/27/2010

NEW YORK, Oct. 27 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) announced today the publication of data showing that 57 percent of ALK-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib (PF-02341066), an investigational oral anaplastic lymphoma kinase (ALK) inhibitor, had either a complete (one patient) or partial (46 patients) response to treatment.  Data from 82 patients in this Part 2 expansion cohort of the Phase 1 study were published in the October 28 issue of the New England Journal of Medicine.(1)

(Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO)

"It is gratifying to learn of responses like those seen in our study of crizotinib (PF-02341066), especially when you consider that most patients had already received two or more therapies by the time they entered the trial," said Dr. Eunice Kwak, MD, Ph.D., department of medicine, Harvard Medical School, assistant in medicine, hematology/oncology, Massachusetts General Hospital and lead author of the study.  "As we're discovering more about lung cancer, we have confirmed the fundamental need to test tumors for molecular changes, like the ALK fusion gene, so we can better identify the patients who may benefit from certain treatments."

Updated results from this study were also recently presented at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, reporting on 113 patients and preliminary median progression-free survival (PFS) data of 9.2 months.(2)

Study A8081001 is a 2-part Phase 1 open-label, multi-center study evaluating crizotinib (PF-02341066), in patients with solid tumors.(3)  The Part 2 expansion cohort from study A8081001 is evaluating the safety and response of crizotinib (PF-02341066) in patients with ALK'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 2015 The Physician-Patient Alliance for Health ... 28, 2015, "Surviving Your Hospital Stay: Physician-Patient Alliance ... Safety." A sentence was omitted from ... "PPAHS is a member of the National Coalition ... information on the National Coalition to Promote Continuous Monitoring ...
(Date:7/31/2015)... Egalet Corporation (Nasdaq: EGLT ) ... on developing, manufacturing and marketing innovative pain treatments, ... underwritten public offering of 7,666,667 shares of its ... $11.25 per share. The shares of common stock ... the exercise in full by the underwriters of ...
(Date:7/31/2015)... , July 31, 2015 ... for video, data and cloud computing operators has ... leading pharma giant for Internet of Things (IoT) ... applications offered on subscription model.      ... giant is striving for business innovations to make ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... 21 Accuray Incorporated (Nasdaq: ARAY ), a ... plans to establish an America,s region thereby establishing regionalized ... , The formation of this new Americas region, ... and Japan, gives each region control of revenue and ...
... , WARSAW, Ind., Oct. 21 Symmetry Medical Inc. (NYSE: ... the global orthopaedic device industry and other medical markets, announced ... for the period ending October 3, 2009 before the market ... an accompanying conference call at 8:00 a.m. ET on Thursday, ...
Cached Medicine Technology:Accuray Announces Regionalized Management Strategy for Americas 2Accuray Announces Regionalized Management Strategy for Americas 3Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009 2
(Date:7/31/2015)... Seattle, WA (PRWEB) , ... July 31, 2015 , ... ... rapidly transforming the way we treat aging diseases. , BioViva announces it has ... to treat patients with Alzheimer’s Disease (AD) and find a cure. MaxLife will grant ...
(Date:7/31/2015)... ... 2015 , ... The Heart Fit Clinic has increased a patient's fitness level ... of 150 beats versus 100 beats, this is a big deal," says Diamond Fernandes, ... back to patients with heart disease," he adds. People with angina are able to ...
(Date:7/31/2015)... ... July 31, 2015 , ... Patients with higher levels ... a study published today in Nature Communications and led by researchers from the Icahn ... that variations in the gene RTN1 led to greater production of the related RNT1 ...
(Date:7/31/2015)... ... ... Indosoft, Inc., is pleased to announce a major update to its agent interface ... ACD system for Asterisk-based call centers . The new features make it easier ... agent only when wanted, and allows for validation of data as the agent enters ...
(Date:7/31/2015)... ... 2015 , ... According to WFLA on July 16th, Sarasota has ... eventual overdoses. Thricefold deaths have held steady over the last “couple of months” according ... epidemic, which was spurred by the crackdown of prescription painkillers. Many users who were ...
Breaking Medicine News(10 mins):Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 3Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 3
... 15 The World Health Organization has increased the pandemic alert ... flu, the first time it has been raised to this level ... themselves, but need not be fearful. The outbreak is considered ... that influenza A (H1N1) is necessarily causing more serious infections, or ...
... ... Staffing Solutions , ... Alpharetta, GA (Vocus) June 14, 2009 -- "Thomas McKeever has been ... marketing thrust--introducing a more streamlined approach to physician staffing at prominent hospitals and ...
... generate infection-fighting proteins called antibodies that either block infection ... disease. Attempts to create a vaccine that induces antibodies ... far been unsuccessful. But several recent studies suggest promising ... HIV vaccine, according to John R. Mascola, M.D., deputy ...
... information exchange , , TORONTO, June 14 ... Toronto this week, Siemens Healthcare will highlight Symbia.net*, the ... for anytime, anywhere processing and reading. Show attendees are ... (#1024). , , (Photo: ...
... can occur, , SUNDAY, June 14 (HealthDay News) -- The ... attention to the issue of brain injury and raised important ... or a loved one. , Richardson died hours after taking ... picked herself up from the fall and refused medical attention, ...
... January to May 2009 sees ... , ... the chairman of MYA Cosmetic Surgery Ltd. and former owner of Transform Medical Group, ... eyelid surgery. John Ryan, 59, has decided to have the procedure which he feels will make ...
Cached Medicine News:Health News:As World Health Organization Raises Influenza A (H1N1) Pandemic Alert to Level Six, Hygiene Council Recommends Simple Steps to Help Protect Families from Illness 2Health News:As World Health Organization Raises Influenza A (H1N1) Pandemic Alert to Level Six, Hygiene Council Recommends Simple Steps to Help Protect Families from Illness 3Health News:Thomas McKeever to Spearhead Jackson & Coker's National Accounts Division 2Health News:Thomas McKeever to Spearhead Jackson & Coker's National Accounts Division 3Health News:NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine 2Health News:Symbia.net - Hotspot for Remote Access 2Health News:Symbia.net - Hotspot for Remote Access 3Health News:For Every Blow to the Head, Quick Action Is Urged 2Health News:For Every Blow to the Head, Quick Action Is Urged 3Health News:Cosmetic Surgery Pioneer Goes Under the Knife 2Health News:Cosmetic Surgery Pioneer Goes Under the Knife 3
Introducing the Guidant HEARTSTRING Proximal Seal System. A surgically intuitive system that meets the challenge of clampless hemostasis with a design that is elegant in its simplicity and profound i...
... The Nidek's ophthalmic Nd: YAG laser YC-1600 ... system of superb versatility and clinical performance., ... Laser (1064nm),, Lightweight Model ,Further weight ... convenient setting in your office.,, Aiming ...
... system, developed by Given Imaging of Israel, is ... a grape. Weighing in at only four grams, ... LED lights, battery and radio transmitter coated by ... digestive enzymes. Internal gastric images are transmitted to ...
... catheter-free Bravo pH Monitoring System ... testing is done. Bravo allows ... diet and activities during pH ... catheter-free, the added convenience for ...
Medicine Products: